Abstract:Background: Calorie restriction (CR) produces a number of health benefits and ameliorates diseases of aging such as type 2 diabetes. The components of the pathways downstream of CR may provide intervention points for developing therapeutics for treating diseases of aging. The NAD+-dependent protein deacetylase SIRT1 has been implicated as one of the key downstream regulators of CR in yeast, rodents, and humans. Small molecule activators of SIRT1 have been identified that exhibit efficacy in animal models of diseases typically associated with aging including type 2 diabetes. To identify molecular processes induced in the liver of mice treated with two structurally distinct SIRT1 activators, SIRT501 (formulated resveratrol) and SRT1720, for three days, we utilized a systems biology approach and applied Causal Network Modeling (CNM) on gene expression data to elucidate downstream effects of SIRT1 activation. Results: Here we demonstrate that SIRT1 activators recapitulate many of the molecular events downstream of CR in vivo, such as enhancing mitochondrial biogenesis, improving metabolic signaling pathways, and blunting pro-inflammatory pathways in mice fed a high fat, high calorie diet. Conclusion: CNM of gene expression data from mice treated with SRT501 or SRT1720 in combination with supporting in vitro and in vivo data demonstrates that SRT501 and SRT1720 produce a signaling profile that mirrors CR, improves glucose and insulin homeostasis, and acts via SIRT1 activation in vivo. Taken together these results are encouraging regarding the use of small molecule activators of SIRT1 for therapeutic intervention into type 2 diabetes, a strategy which is currently being investigated in multiple clinical trials.

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

THE Sirt GENE FAMILY AND ITS ROLE IN REGULATION OF CELL LIFESPAN

Function and Mechanism of Sir2 Gene Family

SIRT1, resveratrol and aging

Advances in Sirtuin on the Mechanism of Calorie Restriction on Lifespan*

Reducing Sphingolipid Synthesis Orchestrates Global Changes To Extend Yeast Lifespan

Sirtuins at the Service of Healthy Longevity

SIRT1 in metabolic syndrome: where to target matters.

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ

Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo

Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans

Resveratrol improves health and survival of mice on a high-calorie diet

Redox control of yeast Sir2 activity is involved in acetic acid resistance and longevity

Sir2 Deletion Prevents Lifespan Extension in 32 Long-Lived Mutants

Genome-Wide Mechanisms of Lifespan Extension by Dietary Restriction in Yeast

SIR2 and other genes are abundantly expressed in long-lived natural segregants for replicative aging of the budding yeast Saccharomyces cerevisiae

The Role of NAD and NAD Precursors on Longevity and Lifespan Modulation in the Budding Yeast, Saccharomyces Cerevisiae

Mutation in the silencing gene S/R4 can delay aging in S. cerevisiae

Molecular Mechanisms of Genotype-Dependent Lifespan Variation Mediated by Caloric Restriction: Insight from Wild Yeast Isolates

SIRT6 in DNA repair, metabolism and ageing

Enhancing lifespan of budding yeast by pharmacological lowering of amino acid pools